keratoplasty
Showing 1 - 25 of 213
DMEK Endothelial Keratoplasty inHistory of Anterior or Posterior
Not yet recruiting
- Patients Undergoing DMEK With a History of Anterior or Posterior Segment Surgery
- Descemet Membrane Endothelial Keratoplasty
- (no location specified)
Aug 22, 2023
Corneal Dystrophies, Hereditary Trial in Rotterdam (Descemet Membrane Endothelial Keratoplasty (DMEK))
Completed
- Corneal Dystrophies, Hereditary
- Descemet Membrane Endothelial Keratoplasty (DMEK)
-
Rotterdam, NetherlandsNetherlands Institute for Innovative Ocular Surgery
Jan 11, 2023
High-risk Corneal Transplantation, Corneal Blindess, Corneal Inflammation Trial (CLP-PEG-MPC, Human donor cornea penetrating
Withdrawn
- High-risk Corneal Transplantation
- +3 more
- CLP-PEG-MPC
- Human donor cornea penetrating keratoplasty
- (no location specified)
Dec 19, 2022
The Viability Control of Human Endothelial Cells Before
Not yet recruiting
- Corneal Transplant Failure
- Corneal Endothelial Cell Loss
- V-Check
-
Brescia, BS, ItalyAzienda Socio Sanitaria Territoriale degli Spedali Civili di Bre
Apr 27, 2023
Corneal Edema, Corneal Endothelial Disorder, Fuchs' Endothelial Dystrophy Trial (DSAEK, DMEK)
Not yet recruiting
- Corneal Edema
- +4 more
- DSAEK
- DMEK
- (no location specified)
Jun 29, 2022
Keratoconus Trial in Guangzhou (Corneal donors predisposed by CXL, Corneal donors stored in corneal storage media)
Not yet recruiting
- Keratoconus
- Corneal donors predisposed by CXL
- Corneal donors stored in corneal storage media
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-Sen University
Jun 14, 2023
Keratoconus Trial (Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146%)
Not yet recruiting
- Keratoconus
- Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% with UV light
- Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% without UV light
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Jan 12, 2023
Fuchs' Endothelial Dystrophy Trial in Boston (Netarsudil Ophthalmic)
Recruiting
- Fuchs' Endothelial Dystrophy
- Netarsudil Ophthalmic
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Aug 23, 2022
Deep Anterior Lamellar Keratoplasty By Anterior Segment Ocular
Not yet recruiting
- Keratoconus
- +2 more
- deep anterior lamellar keratoplasty
- (no location specified)
Apr 19, 2022
Corneal Transplantation Trial in Guangzhou (Limbal transplantation combined with central penetrating keratoplasty)
Recruiting
- Corneal Transplantation
- Limbal transplantation combined with central penetrating keratoplasty
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-Sen University
Feb 22, 2022
Corneal Endothelial Decompensation, Fuchs' Endothelial Dystrophy Trial in Indianapolis, Grand Rapids (Descemet membrane
Recruiting
- Corneal Endothelial Decompensation
- Fuchs' Endothelial Dystrophy
- Descemet membrane endothelial keratoplasty
-
Indianapolis, Indiana
- +1 more
Oct 3, 2022
Fuchs' Endothelial Dystrophy Trial in Freiburg (Supine positioning: 5 days, Supine positioning: 1 days)
Not yet recruiting
- Fuchs' Endothelial Dystrophy
- Supine positioning: 5 days
- Supine positioning: 1 days
-
Freiburg, Baden-Wuerttemberg, GermanyMedical Center - University of Freiburg, Eye Hospital
May 31, 2022
Glaucoma Following Surgery Trial in Montréal (Topical infliximab, No topical infliximab)
Recruiting
- Glaucoma Following Surgery
- Topical infliximab
- No topical infliximab
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Jul 4, 2022
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Descemet Membrane Endothelial Keratoplasty (DMEK) Trial
Recruiting
- Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
- Descemet Membrane Endothelial Keratoplasty (DMEK)
- Nepafenac Ophthalmic
- Dexamethasone Ophthalmic
-
Oslo, NorwayDepartment of Ophthalmology, Oslo University Hospital
Nov 26, 2022
Corneal Endothelial Dystrophy, Corneal Edema Trial in Indianapolis (loteprednol etabonate 0.25% ophthalmic suspension)
Active, not recruiting
- Corneal Endothelial Dystrophy
- Corneal Edema
- loteprednol etabonate 0.25% ophthalmic suspension
-
Indianapolis, IndianaPrice Vision Group
Jan 6, 2023
Track Longitudinal Clinical Outcomes of Corneal Surgery and
Recruiting
- Corneal Disease
- +3 more
- Optical Coherence Tomography
-
Baltimore, MarylandKeratoplasty Alliance International
Oct 23, 2023
Descemet Membrane Endothelial Keratoplasty vs. Descemet's
Recruiting
- Cystoid Macular Edema
- Fuchs Dystrophy
- Optical Coherence Tomography
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Dec 16, 2021
Fuchs Endothelial Dystrophy Trial in Portland (Glanatec, Optive, Ophthalmic Solution, Descemet Membrane Endothelial
Recruiting
- Fuchs Endothelial Dystrophy
- Glanatec
- +2 more
-
Portland, OregonDevers Eye Institute
Sep 2, 2021
Dry Eye Disease Trial in Incheon, Seoul (Charge-Balanced, Symmetric Nerve Stimulation, Sham Stimulation)
Recruiting
- Dry Eye Disease
- Charge-Balanced, Symmetric Nerve Stimulation
- Sham Stimulation
-
Incheon, Korea, Republic of
- +5 more
Nov 8, 2023
Ocular Hypertension Following Deep Anterior Lamellar
Recruiting
- Unrecognized Condition
- antiglaucoma
-
Mansoura, Dakahlyia, EgyptMansoura university
Jun 18, 2021
Irregular Astigmatism Trial in Pristina (Intrastromal Fresh Human Lenticule Implantation)
Active, not recruiting
- Irregular Astigmatism
- Intrastromal Fresh Human Lenticule Implantation
-
Pristina, KosovoEye Hospital Pristina
Jul 27, 2021
Corneal Endothelial Cell Loss, Fuchs' Endothelial Dystrophy Trial in Terrassa (Descemet Stripping Automated Endothelial
Completed
- Corneal Endothelial Cell Loss
- Fuchs' Endothelial Dystrophy
- Descemet Stripping Automated Endothelial Keratoplasty
- Descemet Membrane Endothelial Keratoplasty
-
Terrassa, Barcelona, SpainHospital Universitari Mutua Terrassa
Mar 9, 2021
Fuchs' Endothelial Dystrophy Trial in Vienna (Ultrahigh resolution Spectral Domain OCT)
Completed
- Fuchs' Endothelial Dystrophy
- Ultrahigh resolution Spectral Domain OCT
-
Vienna, Austria
- +1 more
Apr 6, 2022
Keratoconus, Fuchs Dystrophy, Corneal Disease Trial in Southampton (Femtosecond Laser, Trephine blade)
Recruiting
- Keratoconus
- +2 more
- Femtosecond Laser
- Trephine blade
-
Southampton, Hampshire, United KingdomSouthampton Eye Unit
Dec 18, 2020
Fuchs' Endothelial Dystrophy, Cataract Trial in Boston (Netarsudil 0.02% Ophthalmic Solution)
Completed
- Fuchs' Endothelial Dystrophy
- Cataract
- Netarsudil 0.02% Ophthalmic Solution
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Jan 24, 2021